What's happening
This bill requires health insurance policies in New York to cover home test kits for sexually transmitted diseases, including HIV.
Why it matters
Expands access to STD screening. By mandating insurance coverage for home test kits, the bill can make STD and HIV testing more accessible, especially for people who face barriers to visiting clinics, such as privacy concerns, limited mobility, or lack of transportation.
Aligns coverage with public health guidelines. The bill ensures that only tests recommended by the CDC or the US Preventive Services Task Force—and which meet FDA or regulatory standards—are covered, promoting the use of reliable, evidence-based home testing options.
Potential to reduce undiagnosed infections. Easier access to home test kits may lead to earlier detection and treatment of STDs, which can help prevent the spread of infections and reduce long-term health complications at both the individual and community level.
Insurance market impact. Health insurers will need to adjust policy terms, administrative processes, and potentially premiums to accommodate coverage for these home tests, which could have implications for the cost and structure of health plans in New York.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Cover Home STD Test Kits
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Referred to insurance
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
8187
IN SENATE
February 1, 2022
Introduced by Sen. HOYLMAN -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law, in relation to requiring health insurance coverage for home test kits for sexually transmitted diseases
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 36 to read as follows:
(36) Every policy which provides hospital, surgical or medical coverage or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for home test kits for sexually transmitted diseases. For purposes of this paragraph, "home test kit" means a product used for a test recommended by the federal Centers for Disease Control and Prevention guidelines or the United States Preventive Services Task Force, that has been Clinical Laboratory Improvement Amendments of 1988-waived, cleared or approved by the United States Food and Drug Administration, or developed by a laboratory in accordance with established regulations and quality standards, to allow individuals to self-collect specimens for sexually transmitted diseases, including HIV, remotely at a location outside of a clinical setting.
§ 2. Subsection (k) of section 3221 of the insurance law is amended by adding a new paragraph 22 to read as follows:
(22) Every policy which provides hospital, surgical or medical coverage or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for home test kits for sexually transmitted diseases. For purposes of this paragraph, "home test kit" means a product used for a test recommended by the federal Centers for Disease Control and Prevention guidelines or the United States Preventive Services Task Force, that has been Clinical Laboratory Improvement Amendments of 1988-waived, cleared or approved by the United States Food and Drug Administration, or developed by a laboratory in accordance with established regulations and quality standards, to allow
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14420-02-2
individuals to self-collect specimens for sexually transmitted diseases, including HIV, remotely at a location outside of a clinical setting.
§ 3. Section 4303 of the insurance law is amended by adding a new subsection (ss) to read as follows:
(ss) Every policy which provides hospital, surgical or medical coverage or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for home test kits for sexually transmitted diseases. For purposes of this subsection, "home test kit" means a product used for a test recommended by the federal Centers for Disease Control and Prevention guidelines or the United States Preventive Services Task Force, that has been Clinical Laboratory Improvement Amendments of 1988-waived, cleared or approved by the United States Food and Drug Administration, or developed by a laboratory in accordance with established regulations and quality standards, to allow individuals to self-collect specimens for sexually transmitted diseases, including HIV, remotely at a location outside of a clinical setting.
§ 4. This act shall take effect on the ninetieth day after it shall have become a law and shall apply to any policy issued, delivered, renewed, and/or modified on or after the effective date of this act. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law, in relation to requiring health insurance coverage for home test kits for sexually transmitted diseases
Purpose or general idea of bill
To require insurance providers cover at home STD test kits.
Summary of provisions
Section 1 of the bill amends section 3216 of insurance law section to require insurance policies include coverage for STD home test kits.
Section 2 of the bill amends section 3216 of insurance law section to require insurance policies include coverage for STD home test kits.
Section 3 of the bill amends section 3216 of insurance law section to require insurance policies include coverage for STD home test kits.
Section.4 is the effective date.
Justification
Rates of sexually transmitted diseases (STDs) have been trending upward, with reported STDs reaching an all-time high for the sixth year in a row, according to the Centers for Disease Control and Prevention. A recent report found a nearly thirty percent increase in reported STDs between 2015 and 2019. Alarmingly, the most recent data available for 2020 suggests that this trend has only gotten worse, but the COVID-19 pandemic has disrupted our STD testing protocols and staffing capacity, which has left us in the dark about the true state of this parallel epidemic.
The lack of easily available and convenient testing has also contributed to undetected infections that in turn increase the rate of spread of these diseases. While many of these illnesses are treatable, some do not manifest symptoms for extended periods. Without testing, individuals do not seek treatment and are in danger of fatal or severe health conse- quences. This bill helps ensure New York can control the spread and provide treatment for those in need by making convenient at home testing widely available.
Prior legislative history
New bill
Fiscal implications to state and local governments
None
Effective date
This act shall take effect on the ninetieth day after it shall have become a law and shall apply to any policy issued, delivered, renewed, and/or modified on or after the effective date of this act. Effective immediately, the addition, amendment and/or repeal of any rule or regu- lation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.